Drug Shortage Report for CITALOPRAM
Report ID | 246702 |
Drug Identification Number | 02430541 |
Brand name | CITALOPRAM |
Common or Proper name | Citalopram Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 3x10 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-12-23 |
Estimated end date | 2025-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-04-10 |
Company comments | Bottle 100 under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2025-04-10 | French | Compare |
v8 | 2025-04-10 | English | Compare |
v7 | 2025-03-18 | French | Compare |
v6 | 2025-03-18 | English | Compare |
v4 | 2025-01-03 | French | Compare |
v5 | 2025-01-03 | French | Compare |
v3 | 2025-01-03 | English | Compare |
v2 | 2025-01-03 | French | Compare |
v1 | 2025-01-03 | English | Compare |
Showing 1 to 9 of 9